Details for Patent: 6,403,616
✉ Email this page to a colleague
Summary for Patent: 6,403,616
Title: | Chemical process and pharmaceutical formulation |
Abstract: | Process for the manufacturing of slightly soluble or less soluble alkaline salts of substituted sulphinyl heterocycles containing an imidazole moiety with formula I ##STR1## preferably alkaline salts of a proton pump inhibitor compound, wherein the process comprises the step of reacting the substituted sulphinyl heterocycle of Formula I with a source of the cation in the presence of a base, characterized by a washing step in which the prepared alkaline salt of the substituted sulphinyl compound is washed with a basic aqueous solvent mixture. The obtained bulk drug substance resulting in a bulk product that in an aqueous suspension of the substituted sulphinyl heterocycle having a pH not significantly lower than that of a saturated water solution of the pure compound prepared. Alternatively, the process for manufacturing a pharmaceutical dosage form comprising the active substance could be adjusted. For instance the pH of an aqueous suspension of the active substance is adjusted to a pH not significantly lower than that of a saturated water solution of the pure compound. The processes are preferably useful in the manufacturing of omeprazole magnesium salt or magnesium salt of one of its single enantiomers used in pharmaceutical dosage forms. |
Inventor(s): | Erickson; Magnus (Vastra Frolunda, SE), Gustavsson; Anders (Nykvarn, SE), Josefsson; Lars (Savedalen, SE) |
Assignee: | AstraZeneca AB (Sodertalje, SE) |
Application Number: | 09/485,897 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,403,616 |
Patent Claim Types: see list of patent claims | Compound; Process; Dosage form; Use; |
Drugs Protected by US Patent 6,403,616
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 6,403,616
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Sweden | 9803952 | Nov 18, 1998 |
Sweden | 9803953 | Nov 18, 1998 |
PCT Information | |||
PCT Filed | November 15, 1999 | PCT Application Number: | PCT/SE99/02093 |
PCT Publication Date: | May 25, 2000 | PCT Publication Number: | WO00/28975 |
International Family Members for US Patent 6,403,616
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 271556 | ⤷ Try a Trial | |||
Australia | 1901700 | ⤷ Try a Trial | |||
Australia | 770633 | ⤷ Try a Trial | |||
Brazil | 9915421 | ⤷ Try a Trial | |||
Canada | 2347981 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |